Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Three separate data streams converged on C.H. Robinson Worldwide this week. Options positioning shifted, cost to borrow jumped, and retail attention spiked after a single-day 10% fall. None of these signals sits in extreme territory on its own. Together, they point to a market increasingly unsettled ahead of the October 28 earnings date.
The put-call ratio hit 0.3564 on October 7, 2.5 standard deviations above its 20-day mean of 0.3044. That is the most defensive options positioning seen on CHRW in recent weeks, though it remains well below the 52-week high of 0.497. The move followed the stock's 10.8% single-day drop on October 6. Put buyers stepped up after the fall, not before it, suggesting the options activity reflects concern about further weakness rather than a predictive positioning event.
Wikipedia views and ORTEX page traffic combined to push a retail attention reading to 2.77 standard deviations above its own 90-day average as of October 6. This is an attention signal, not a revenue or earnings indicator. It tells you the stock is being watched more closely than usual, consistent with a sharp single-day drop drawing in observers who would not normally track a freight broker.
Cost to borrow rose to 0.50%, up roughly 220% over one week from near-zero levels. In absolute terms it is still low. Availability sits at 8,749% of short interest, meaning the lending pool holds roughly 87 shares available for every one currently borrowed. Borrowing CHRW shares is not difficult. The CTB move reflects the recent stock price volatility rather than any tightening in borrow supply.
Short interest stands at 4.1% of free float, edging slightly lower over the past week. The ORTEX short score sits at 35.6, broadly unchanged over the past two weeks. Neither reading supports a bear thesis built on positioning pressure.
The more relevant context is the earnings setup. Three analysts cut price targets in three consecutive days this week. JP Morgan, Evercore ISI, and Truist all maintained positive ratings while trimming to the $198 to $217 range. The mean consensus target is around $198, roughly 47% above the current $135.18 close. The last earnings print, in late July, produced a 13% single-day drop.
See the live data behind this article on ORTEX.
Open CHRW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
